Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose-response of remimazolam for induction of anesthesia in children
ChiCTR2200061886Phase 4Not yet recruiting
- Sponsor
- First Affiliated Hospital of Anhui Medical University
- Start
- Jun 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of remimazolam, sponsored by First Affiliated Hospital of Anhui Medical University. Primary endpoints: MOAA/S score and Bispectral index (BIS). Planned start Jun 2022; status: not yet recruiting.
02
Drugs
remimazolam
Beyond the preview
Go deeper on ChiCTR2200061886.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200061886.